FRANKLYN G PRENDERGAST Insider Trading $CGIX Vyant Bio, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANKLYN G PRENDERGAST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANKLYN G PRENDERGAST. FRANKLYN G PRENDERGAST is Director in LILLY ELI & CO ($LLY) and Director in NeuBase Therapeutics, Inc. ($OHRP) and Director in CANCER GENETICS, INC ($CGIX) and Director in Lantern Pharma Inc. ($LTRN).
FRANKLYN G PRENDERGAST in Vyant Bio, Inc.
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 12,500 shares
Current Value: $30,000
Latest Transaction: Aug 21 2019
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANKLYN G PRENDERGAST in Vyant Bio, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LLY, LTRN, NBSE, CGIX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2019 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
| Oct 02 2017 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 2.75 | 5,000 | 13,750 | 5,000 | |
| Oct 02 2017 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Jun 08 2017 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
| Jun 08 2017 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Oct 13 2016 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 1.81 | 10,000 | 18,100 | 10,000 | |
| Oct 13 2016 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| May 18 2015 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 |
Page: 1